Shames Richard S.
Insider CIK 1675878 · PTGX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | S Sale | 2019-03-01 | 2019-03-04 | 657 | $8.03 | $5.3K | 32,021 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-02-28 | 2019-03-04 | 51,000 | — | $0 | 51,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2019-02-28 | 2019-03-04 | 8,500 | — | $0 | 32,678 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-02-06 | 2019-02-08 | 198 | $8.15 | $1.6K | 26,758 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-02-06 | 2019-02-08 | 2,580 | $7.71 | $19.9K | 24,178 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-08-15 | 2018-08-17 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-08-15 | 2018-08-17 | 18,750 | — | $0 | 26,956 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-02-28 | 2018-03-02 | 37,500 | — | $0 | 37,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-02-28 | 2018-03-02 | 6,500 | — | $0 | 6,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-22 | 2017-12-27 | 3,529 | — | $0 | 33,273 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-12-22 | 2017-12-27 | 3,529 | $20.50 | $72.3K | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-22 | 2017-12-27 | 3,529 | $4.21 | $14.9K | 3,529 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-10-05 | 2017-10-10 | 2,017 | — | $0 | 36,802 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-10-05 | 2017-10-10 | 2,017 | $19.00 | $38.3K | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-10-05 | 2017-10-10 | 2,017 | $4.21 | $8.5K | 2,017 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-09-12 | 2017-09-12 | 3,687 | $14.31 | $52.8K | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-08-29 | 2017-08-30 | 1,512 | — | $0 | 38,819 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-08-29 | 2017-08-30 | 1,512 | $4.21 | $6.4K | 3,377 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-08-29 | 2017-08-30 | 1,512 | $17.00 | $25.7K | 1,865 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2016-10-11 | 2016-10-13 | 65,000 | — | $0 | 65,000 | SEC↗ |